Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Profession Cataract, Cornea / Ocular Surface, Refractive, Professional Development

Selecting for Patient Success

At a Glance

  • A small subpopulation of patients experience poor outcomes after surgery
  • Diagnostics and screening can help identify this problematic group
  • Objective assessment of overall visual quality is a first step
  • Topography and aberrometry further enhance outcomes

Eighty-five to 95 percent of the time, outcomes in cataract, refractive, and corneal inlay surgery are excellent (1,2). To help with that troublesome last 5-15 percent, we now have numerous advances in surgical technology, novel diagnostic equipment and improved patient screening at our disposal. Major improvements in laser technology through faster excimer lasers, more accurate eye trackers, and very precise femtosecond lasers mean that much of the potential for human error during surgery has been eliminated.  It is now up to us to use the best diagnostic devices available to ensure that patients who are poor candidates do not slip through the safety net of proper screening. Here are my views on the diagnostic technologies that help to achieve optimal outcomes.

Read the full article now

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

alain saad

Alain Saad

Alain Saad specializes in cornea, cataract and refractive surgery at the Rothschild Foundation in Paris. He is a proponent of Descemet membrane endothelial keratoplasty (DMEK) and is working to generalize the procedure for treatment of endothelial disease. Alain co-developed the SCORE analyzer for the pre-operative screening of corneas.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register